Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-003384
Filing Date
2025-04-09
Accepted
2025-04-09 14:58:50
Documents
59
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1235557
2 ex4-5.htm EX-4.5 137829
3 ex21-1.htm EX-21.1 1988
4 ex31-1.htm EX-31.1 17303
5 ex32-1.htm EX-32.1 7553
6 ex97.htm EX-97 22010
7 form10-k_001.jpg GRAPHIC 5178
  Complete submission text file 0001641172-25-003384.txt   5460908

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ftii-20241231.xsd EX-101.SCH 35876
9 XBRL CALCULATION FILE ftii-20241231_cal.xml EX-101.CAL 44601
10 XBRL DEFINITION FILE ftii-20241231_def.xml EX-101.DEF 210552
11 XBRL LABEL FILE ftii-20241231_lab.xml EX-101.LAB 332844
12 XBRL PRESENTATION FILE ftii-20241231_pre.xml EX-101.PRE 287891
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 599062
Mailing Address 128 GAIL DRIVE NEW ROCHELLE NY 10805
Business Address 128 GAIL DRIVE NEW ROCHELLE NY 10805 9143164805
FutureTech II Acquisition Corp. (Filer) CIK: 0001889450 (see all company filings)

EIN.: 872551539 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41289 | Film No.: 25824952
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)